Candida auris: An emerging drug resistant yeast - A mini-review

J Mycol Med. 2018 Sep;28(3):568-573. doi: 10.1016/j.mycmed.2018.06.007. Epub 2018 Jul 17.

Abstract

Candida auris is an emerging fungal pathogen responsible for nosocomial invasive infection outbreaks on five continents. Large healthcare-related outbreaks of C. auris infection and colonization have been reported from different countries. Whole genome sequence analysis identified strong phylogeographic C. auris clades specific to particular geographical areas suggesting transmission of particular clades within countries. However, the mode of transmission within the healthcare environment is not clear and is likely to be multifactorial. The emergence of C. auris is alarming because this organism can harbor or develop multidrug resistance. This explains why C. auris infections are difficult to treat. In addition, difficulties in its identification in the routine diagnostic laboratory have a significant impact on outbreak detection and management. This mini-review highlights the available literature on C. auris, with particular insight into its epidemiology and the problems caused by its antifungal resistance.

Keywords: Antifungal; Candida auris; Control strategy; Epidemiology; Multi-drug resistance; Prevention; Treatment.

Publication types

  • Review

MeSH terms

  • Animals
  • Candida / genetics
  • Candida / growth & development
  • Candida / isolation & purification*
  • Communicable Diseases, Emerging / microbiology*
  • Drug Resistance, Fungal* / genetics
  • Drug Resistance, Multiple, Fungal / genetics
  • Humans
  • Microbial Sensitivity Tests
  • Virulence Factors / genetics

Substances

  • Virulence Factors